These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12654975)

  • 21. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
    Zisimopoulou P; Evangelakou P; Tzartos J; Lazaridis K; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Frenkian Cuvelier M; Stojkovic T; DeBaets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Tzartos SJ
    J Autoimmun; 2014 Aug; 52():139-45. PubMed ID: 24373505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Epidemiology of Myasthenia Gravis in Korea.
    Lee HS; Lee HS; Shin HY; Choi YC; Kim SM
    Yonsei Med J; 2016 Mar; 57(2):419-25. PubMed ID: 26847295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Late onset forms of myasthenia gravis. Comparison with early-onset myasthenia gravis].
    Barbaud A; Carlander B; Pagès M
    Rev Neurol (Paris); 2006 Oct; 162(10):990-6. PubMed ID: 17028567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data.
    Keovilayhong S; Mulliez A; Feral L; Chenaf C; Clavelou P; Moisset X; Taithe F; Poncet Megemont L
    Rev Neurol (Paris); 2024 May; 180(5):451-458. PubMed ID: 38582663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease.
    Toth C; McDonald D; Oger J; Brownell K
    Acta Neurol Scand; 2006 Aug; 114(2):124-32. PubMed ID: 16867036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989.
    Christensen PB; Jensen TS; Tsiropoulos I; Sørensen T; Kjaer M; Højer-Pedersen E; Rasmussen MJ; Lehfeldt E; de Fine Olivarius B
    Neurology; 1993 Sep; 43(9):1779-83. PubMed ID: 8414031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological and immunological profile of muscle-specific kinase myasthenia gravis in Greece.
    Tsiamalos P; Kordas G; Kokla A; Poulas K; Tzartos SJ
    Eur J Neurol; 2009 Aug; 16(8):925-30. PubMed ID: 19374661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of myasthenia gravis in the province of Ferrara: a community-based study.
    Casetta I; Fallica E; Govoni V; Azzini C; Tola M; Granieri E
    Neuroepidemiology; 2004; 23(6):281-4. PubMed ID: 15297794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and impact of myasthenia gravis disease in Australian patients.
    Blum S; Lee D; Gillis D; McEniery DF; Reddel S; McCombe P
    J Clin Neurosci; 2015 Jul; 22(7):1164-9. PubMed ID: 26021730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis.
    Klein R; Marx A; Ströbel P; Schalke B; Nix W; Willcox N
    Hum Immunol; 2013 Sep; 74(9):1184-93. PubMed ID: 23792059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England.
    Robertson NP; Deans J; Compston DA
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):492-6. PubMed ID: 9771771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Some epidemiological aspects of myasthenia gravis in Cuba].
    Cisneros AD; Luis RS; León R; Carrera PL
    Rev Neurol; 1996 Apr; 24(128):435-9. PubMed ID: 8721922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A national epidemiological study of Myasthenia Gravis in Australia.
    Gattellari M; Goumas C; Worthington JM
    Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis.
    Aurangzeb S; Tariq M; Irshad M; Badshah M; Khan RS
    J Pak Med Assoc; 2009 May; 59(5):289-92. PubMed ID: 19438131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myasthenia gravis incidence in a general North Atlantic isolated population.
    Joensen P
    Acta Neurol Scand; 2014 Oct; 130(4):222-8. PubMed ID: 24981565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myasthenia gravis: a disease of the very old.
    Aragonès JM; Roura-Poch P; Hernández-Ocampo EM; Alonso F; Pont-Lluelles M; Xandri I; Bolíbar I; Illa I
    J Am Geriatr Soc; 2014 Jan; 62(1):196-7. PubMed ID: 25180387
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical aspects of myasthenia explained.
    Verschuuren JJ; Palace J; Gilhus NE
    Autoimmunity; 2010 Aug; 43(5-6):344-52. PubMed ID: 20380587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of myasthenia gravis in the province of Trento (northern Italy).
    Ferrari G; Lovaste MG
    Neuroepidemiology; 1992; 11(3):135-42. PubMed ID: 1407249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Geographical distribution of a seropositive myasthenia gravis population.
    Heldal AT; Eide GE; Gilhus NE; Romi F
    Muscle Nerve; 2012 Jun; 45(6):815-9. PubMed ID: 22581533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology.
    Tsinzerling N; Lefvert AK; Matell G; Pirskanen-Matell R
    J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1109-12. PubMed ID: 17353257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.